Compared with placebo, a 72-hour infusion of 1 ng/kg/min iloprost does not improve outcomes or reduce the severity of organ failure among patients admitted to the intensive care unit (ICU ...

Iloprost was approved by the FDA for use in the U.S. earlier this year, but is still not commercially available in this country. It currently requires a special access request to Health Canada.

The US regulator has cleared Aurlumyn (iloprost) injection from CiVi Biopharma subsidiary Eicos Sciences as a treatment for severe frostbite, caused by prolonged exposure to extreme cold ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

Iloprost Ineffective for Organ Dysfunction in Septic Shock In a trial of intensive care unit patients with septic shock and high soluble thrombomodulin levels, iloprost infusions for 72 hours did ...